STAT

JULY 31, 2024

Mount Sinai, a leading hospital network in New York City, has mounted an extraordinary behind-the-scenes campaign to blunt the fallout over revelations about its controversial research project in which brain biopsies are taken from patients undergoing deep brain stimulation, STAT has learned. That has included not only enlisting its own patients to defend the research but also seeking to stop a professional society of neurosurgeons from issuing a statement that could have jeopardized the researc

Documentation 145

Documentation FDA Hospitals 145

Drug Topics

JULY 31, 2024

The investigational oral, selective NaV1.8 pain signal inhibitor from Vertex Pharmaceuticals demonstrated a favorable benefit/risk profile in 3 phase 3 trials.

FDA 123

FDA 123

STAT

JULY 31, 2024

Untreated vision loss and high LDL cholesterol have been added as two new potentially modifiable risk factors for dementia in a report released Wednesday by the Lancet Commission. These new additions join 12 other risk factors outlined by the commission, affiliated with University College London, in previous reports on dementia prevention, intervention, and care in 2017 and 2020.

145

145

Pharmacy Times

JULY 31, 2024

Pharmacies can adapt by embracing digital self-service options to better engage with patients, meet increasing consumer demand, and enhance revenue streams.

138

138

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

STAT

JULY 31, 2024

CHICAGO — “Buttery Biscuits & Hot Honey Gravy,” mushroom jerky, soy chicken nuggets, strawberry champagne donuts, plant-based frozen yogurt and buñuelos, white cheddar cheese puffs, chocolatey cookie dippers, egg-free Spanish cheesecake, plant-based chorizo-style empanadas … I was at the annual gathering of food technologists this month to learn about, well, food technology, and I had found myself in the exhibit hall, testing how much I could eat before needi

144

144

Drug Topics

JULY 31, 2024

Catch up on important immunization news from the month of July.

Immunization 187

Immunization Vaccines 187

Fierce Healthcare

JULY 31, 2024

Humana affirmed its guidance for the year as it continues to face headwinds in the Medicare Advantage (MA) space. | Humana affirmed its guidance for the year as it continues to face headwinds in the Medicare Advantage space.

135

135

Drug Topics

JULY 31, 2024

Anisha Patel, PharmD, a pharmacist turned podcast host, shares insights on leveraging all the opportunities pharmacy has to offer to build a diverse and rewarding career.

112

112

Pharmacy Times

JULY 31, 2024

Patients with MDD may also seek complementary or alternative therapies in the form of dietary supplements which might be perceived by patients to be natural and safer than medicinal agents.

123

123

STAT

JULY 31, 2024

The Biden administration isn’t doing enough to ensure people living in recovery housing have access to gold-standard addiction medications like methadone and buprenorphine , according to a coalition of health care, harm reduction, and addiction recovery groups.  The discrimination that people often face when seeking treatment using methadone or buprenorphine, the groups say, is especially pronounced within recovery housing facilities, which typically offer lodging coupled with counse

125

125

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JULY 31, 2024

The findings indicate that zoster vaccine recombinant reduced dementia risk by 17% in an analysis of over 200,000 patients.

Vaccines 145

Vaccines 145

Fierce Healthcare

JULY 31, 2024

In its first quarter with new CEO Chuck Divita, national telehealth provider Teladoc Health posted a net loss of $838 million in Q2 that included a nearly $800 million impairment charge a | Teladoc said on its earnings call on Wednesday that challenges with BetterHelp and increasing advertising costs led its revenue to decline in Q2.

129

129

Fierce Pharma

JULY 31, 2024

Four months after Bayer handed pink slips to 90 staffers at its U.S. headquarters in Whippany, New Jersey, the company is laying off 70 more workers at the site. | Four months after Bayer handed pink slips to 90 staffers at its U.S. headquarters in Whippany, New Jersey, the company is laying off 70 more at the site, according to a state Worker Adjustment and Retraining Notification.

121

121

pharmaphorum

JULY 31, 2024

Frontiers Health 2024 is a platform connecting innovators and changemakers in the life sciences industry to cultivate positive changes in health systems. Discover the latest trends and insights in healthcare innovation.

118

118

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

JULY 31, 2024

In my third week as a medical intern, I learned a vital lesson about the realities of everyday medicine that textbooks and professors hadn’t taught me: how profoundly the financial cost of care affects patients. I was caring for a man admitted to the hospital with uncontrolled atrial fibrillation, an irregular and often rapid heartbeat. After much deliberation, I prescribed a new anticoagulant to prevent the formation of blood clots in his heart, instructed him to continue using his curre

Medical Schools 118

Medical Schools Hospitals 118

Drug Topics

JULY 31, 2024

Researchers aimed to address the change in trust individuals exhibited regarding US physicians and hospitals during the COVID-19 pandemic.

Hospitals 112

Hospitals 112

Fierce Healthcare

JULY 31, 2024

Wells Fargo is the most recent corporation to get sued, as alleged by former employees, for inadequately overseeing the price workers were forced to pay for prescription drug prices. | Wells Fargo was named as a defendant in a new lawsuit for not protecting its workers from extreme prescription drug prices inflicted by Cigna's PBM, Express Scripts.

121

121

pharmaphorum

JULY 31, 2024

Ensuring equitable access to medications remains a fundamental commitment for many pharmaceutical companies to their customers, patients, and stakeholders. However, there has been a discernible shift recently in the timing of access discussions.

Pharmaceutical Companies 111

Pharmaceutical Companies Pharmaceutical Companies 111

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

JULY 31, 2024

There are 75,000 homeless people in Los Angeles County, a county that is the size of Delaware and Rhode Island combined and has a population that is larger than 40 states. | L.A. Care Health Plan is sending social workers to temporary housing sites in Los Angeles County to find more permanent housing solutions.

125

125

Fierce Pharma

JULY 31, 2024

On the heels of game-changing trial results presented at la | On the heels of game-changing trial results presented at last year's ASH meeting, J&J is introducing what it calls a "foundational frontline therapy" in multiple myeloma and at the same time expanding its already impressive presence in the field.

FDA 112

FDA 112

pharmaphorum

JULY 31, 2024

Vertex has filed for FDA approval of its non-opioid pain drug suzetrigine, starting the clock ticking on a review that should be completed early next year

FDA 117

FDA 117

Fierce Healthcare

JULY 31, 2024

Bicycle Health, a virtual provider of opioid use disorder (OUD) treatment, is launching a program for teens in the state of Maine. | The company says this is the first program of its kind in the country. Patients 16 and 17 years of age will be eligible for medications for opioid use disorder via telehealth under the model. Bicycle decided to offer it in the state after hearing about a need directly from one of its payer partners.

110

110

Pharmacy Times

JULY 31, 2024

The presence of glutamic acid decarboxylase antibodies in intravenous immunoglobulin can lead to a misdiagnosis of type 1 diabetes mellitus if a false-positive result is garnered.

139

139

STAT

JULY 31, 2024

Good morning. We have a new investigation out today about how Mount Sinai in New York mounted an aggressive campaign to stifle debate over its controversial brain research. Check it out here. And let’s get into the biotech news.

110

110

Fierce Pharma

JULY 31, 2024

The end of an era is nearing for Lundbeck. After a 17-year collaboration with Takeda on depression drug Trintellix, the Danish drugmaker is passing over its U.S. rights to its partner. | Lundbeck will collect only royalties on Takeda's U.S. sales of the partners' depression med as it reallocates resources to other growth drivers such as antipsychotic Rexulti.

105

105

STAT

JULY 31, 2024

Good morning, folks! The Dean of Pharmalittle University, Ed Silverman, is out on vacation. I also recently went on a mini-vacation, traveling up to a lake house for fun with friends. I’ll be writing my “What I did on summer vacation” essay later this week. But first, the news. … A new study suggests that an older GLP-1 drug may help protect the brains of people with early Alzheimer’s disease, supporting the case for further research on this class of medication

Vaccines 103

Vaccines 103

pharmaphorum

JULY 31, 2024

Patient advocacy group APIC has started a campaign to stop Novo Nordisk from following through on a plan to stop making insulin product Levemir

113

113

Fierce Pharma

JULY 31, 2024

The whole respiratory syncytial virus (RSV) vaccine field took a beating when the Centers for Disease Control and Prevention’s (CDC's) immunization committee doled out a limited recommendation last | The whole RSV vaccine field took a beating when the CDC’s immunization committee doled out a limited recommendation last month. And it’s showing in GSK’s forecast for 2024, just as the company’s Shingrix disappointed.

Vaccines 102

Vaccines Immunization 102

STAT

JULY 31, 2024

Want to stay on top of health news?  Sign up  to get our Morning Rounds newsletter in your inbox. Surprisingly, a story by my colleagues Nick Florko and Sarah Owermohle about how Grindr hired a Washington lobbyist is NOT the first time the, uh, “social networking app” (their words!) has appeared in STAT reporting. A quick Google search tells me that the word first appeared in an early episode of The Readout LOUD.

103

103

pharmaphorum

JULY 31, 2024

GSK raises 2024 forecasts on a strong Q2 led by HIV and cancer drugs, but its shares weakened on litigation concerns and weaker vaccine expectations

Vaccines 109

Vaccines 109

Pharmaceutical Technology

JULY 31, 2024

Gene therapy research is expensive. Biotechs invest millions of dollars in early research to develop therapies for conditions that might be rare. But when funds are limited and the market potential is dim, such programs are often abandoned by companies, leaving patients and investigators in a bind.

98

98

Fierce Pharma

JULY 31, 2024

Even with new entrants edging into the crowded irritable bowel disease (IBD) market and potentially threatening Entyvio’s spot as the market leader, Takeda figures its product still has room to gro | With a new subcutaneous formulation for Entyvio, the Japanese drugmaker isn't worried about new entrants affecting its leading spot in the first-line IBD market over the long run.

97

97

pharmaphorum

JULY 31, 2024

Eisai, Biogen report data showing benefit of Alzheimer's disease therapy Leqembi builds with time, with no increase in safety risk

109

109